Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

alpha1-Antitrypsin deficiency in nonsmokers.

L F Black, F Kueppers

    The American Review of Respiratory Disease
    |March 1, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Alpha-1 antitrypsin deficiency (AATD) patients who never smoked showed variable disease progression. Avoiding respiratory irritants may lead to a better prognosis for individuals with this genetic condition.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Maternal and neonatal outcomes associated with illness severity of maternal COVID-19.

    Journal of neonatal-perinatal medicine·2024
    Same author

    The role of augmentation therapy in alpha-1 antitrypsin deficiency.

    Current medical research and opinion·2011
    Same author

    Oral ketamine in hepatocellular carcinoma.

    Pain medicine (Malden, Mass.)·2004
    Same author

    Role of alpha-1-antichymotrypsin deficiency in promoting cirrhosis in two siblings with heterozygous alpha-1-antitrypsin deficiency phenotype SZ.

    Gut·2002
    Same author

    Alpha1-antichymotrypsin globules within hepatocytes in patients with chronic hepatitis C and cirrhosis.

    Human pathology·2000
    Same author

    Polymorphism of alpha 1-antitrypsin in North American species of Canis.

    The Journal of heredity·2000

    Area of Science:

    • Pulmonology
    • Genetics
    • Internal Medicine

    Background:

    • Alpha-1 antitrypsin deficiency (AATD) is a genetic disorder that increases the risk of lung disease.
    • The PiZ phenotype is the most common genetic variant associated with AATD.
    • Environmental factors, such as smoking and air pollution, are known to exacerbate lung damage in AATD patients.

    Purpose of the Study:

    • To investigate the clinical course and pulmonary function in never-smokers with AATD (PiZ phenotype).
    • To compare the outcomes of never-smokers with AATD to those who smoke.
    • To identify factors influencing the development of chronic obstructive pulmonary disease (COPD) in AATD patients.

    Main Methods:

    • Retrospective analysis of 18 never-smoker patients with AATD (PiZ phenotype).

    Related Experiment Videos

  • Assessment of clinical symptoms, pulmonary function tests, and chest X-ray findings.
  • Comparison with a cohort of PiZ phenotype patients who were smokers.

    • Main Results:

    • Never-smokers with AATD exhibited variable clinical presentations and rates of pulmonary function decline.
    • Chest X-ray findings in never-smokers were also variable.
    • Many never-smokers with AATD lived into their 60s and 70s, indicating a potentially better prognosis than previously assumed.

    Conclusions:

    • Factors beyond AATD phenotype and environmental pollutants influence COPD development.
    • Avoiding respiratory irritants may improve the long-term outlook for individuals with AATD.
    • These findings have implications for the diagnosis and management of AATD patients.